Synthesis of a NO-releasing prodrug of rofecoxibENGELHARDT, F. Conrad; SHI, Yao-Jun; COWDEN, Cameron J et al.Journal of organic chemistry. 2006, Vol 71, Num 2, pp 480-491, issn 0022-3263, 12 p.Article

Vascularite cutanée liée au rofécoxib = Rofecoxib-related cutaneous vasculitisDEFUENTES, Gilles; LECOULES, Stéphane; COUTANT, Gilles et al.La Presse médicale (1983). 2005, Vol 34, Num 14, pp 1007-1008, issn 0755-4982, 2 p.Article

Rofecoxib versus magnesium sulfate to arrest preterm labor: A randomized trialMCWHORTER, Jeannie; CARLAN, S. J; O'LEARY, Timothy D et al.Obstetrics and gynecology (New York. 1953). 2004, Vol 103, Num 5, pp 923-930, issn 0029-7844, 8 p., 2Article

The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticariaBOEHNCKE, W-H; LUDWIG, R. J; ZOLLNER, T. M et al.British journal of dermatology (1951). 2003, Vol 148, Num 3, pp 604-606, issn 0007-0963, 3 p.Article

Selective COX-2 inhibition and cardiovascular effects: A review of the rofecoxib development programWEIR, Matthew R; SPORTING, Rhoda S; REICIN, Alise et al.The American heart journal. 2003, Vol 146, Num 4, pp 591-604, issn 0002-8703, 14 p.Article

A placebo-controlled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomyGILRON, Ian; ORR, Elizabeth; DONGSHENG TU et al.Pain (Amsterdam). 2005, Vol 113, Num 1-2, pp 191-200, issn 0304-3959, 10 p.Article

The time to onset and overall analgesic efficacy of rofecoxib 50 mg : A meta-analysis of 13 randomized clinical trialsDESJARDINS, Paul J; MEHLISCH, Donald R; CHANG, David J et al.The Clinical journal of pain. 2005, Vol 21, Num 3, pp 241-250, issn 0749-8047, 10 p.Article

The preventive effect of rofecoxib in postoperative intraperitoneal adhesionsALDEMIR, M; ÖZTÜRK, H; ERTEN, G et al.Acta chirurgica Belgica. 2004, Num 1, pp 97-100, issn 0001-5458, 4 p.Conference Paper

Dysmenorrhea treatment with a single daily dose of rofecoxibSAHIN, I; SARACOGLU, F; KURBAN, Y et al.International journal of gynaecology and obstetrics. 2003, Vol 83, Num 3, pp 285-291, issn 0020-7292, 7 p.Article

Use of Nonsteroidal Antiinflammatory Drugs: Is There a Change in Patient Risk Profile After Withdrawal of Rofecoxib?RAHME, Elham; ROUSSY, Jean-Pascal; LAFRANCE, Jean-Philippe et al.Journal of rheumatology. 2011, Vol 38, Num 2, pp 195-202, issn 0315-162X, 8 p.Article

Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitorOKUMURA, Takako; MURATA, Yoko; HIZUE, Masanori et al.European journal of pharmacology. 2006, Vol 539, Num 1-2, pp 125-130, issn 0014-2999, 6 p.Article

Experience of rofecoxib in patients with osteoarthritis previously treated with traditional non-steroidal anti-inflammatory drugs in Spain: results of phase 2 of the VICOXX studyARBOLEYA, Luis R; DE LA FIGUERA, Enrique; GARCIA, Maria Soledad et al.Current medical research and opinion. 2003, Vol 19, Num 4, pp 288-297, issn 0300-7995, 10 p.Article

Patient characteristics associated with prescribing of a newly introduced drug : the case of rofecoxibFLORENTINUS, Stefan R; NIELSEN, Merete W; VAN DIJK, Liset et al.European journal of clinical pharmacology. 2005, Vol 61, Num 2, pp 157-159, issn 0031-6970, 3 p.Article

Interaction of inducible nitric oxide synthase and cyclooxygenase-2 inhibitors in formalin-induced nociception in miceDUDHGAONKAR, Shailesh P; KUMAR, Dinesh; NAIK, Ajit et al.European journal of pharmacology. 2004, Vol 492, Num 2-3, pp 117-122, issn 0014-2999, 6 p.Article

Adverse drug events involving COX-2 inhibitorsVERRICO, Margaret M; WEBER, Robert J; MCKAVENEY, Teresa P et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 9, pp 1203-1213, issn 1060-0280, 11 p.Article

Rofecoxib impairs adipose tissue development in a murine model of nutritionally induced obesityROGER LIJNEN, H; VAN HOEF, Berthe; HUA RONG LU et al.Thrombosis and haemostasis. 2008, Vol 100, Num 2, pp 338-342, issn 0340-6245, 5 p.Article

What therapies have replaced rofecoxib in Ireland?TEELING, Mary; O'CONNOR, Humphrey; FEELY, John et al.British journal of clinical pharmacology. 2007, Vol 64, Num 4, pp 536-541, issn 0306-5251, 6 p.Article

The effect of the withdrawal of rofecoxib on prescribing patterns of COX-2 inhibitors in ScotlandWILLIAMS, D; SINGH, M; HIND, C et al.British journal of clinical pharmacology. 2006, Vol 62, Num 3, pp 366-368, issn 0306-5251, 3 p.Article

Factors associated with celecoxib and rofecoxib utilizationRAWSON, Nigel S. B; NOURJAH, Parivash; GROSSER, Stella C et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 4, pp 597-602, issn 1060-0280, 6 p.Article

Preoperative use of selective COX-II inhibitors for pain management in laparoscopic Nissen fundoplicationALANOGLU, Z; ATES, Y; ORBEY, B. C et al.Surgical endoscopy. 2005, Vol 19, Num 9, pp 1182-1187, issn 0930-2794, 6 p.Article

Prescription du rofécoxib en pratique médicale courante : résultats d'une enquete française = Prescribing patterns of rofecoxib in the primary care setting: results of a French surveyBANNWARTH, B; LOGEART, I; VERGULT, G et al.La Revue de médecine interne (Paris). 2004, Vol 25, Num 10, pp 710-714, issn 0248-8663, 5 p.Article

Bioequivalence study of rofecoxib tabletsKOYTCHEV, Rossen; OZALP, Yildiz; ERENMEMISOGLU, Aydin et al.Arzneimittel-Forschung. 2004, Vol 54, Num 9A, pp 624-628, issn 0004-4172, 5 p.Article

Evaluation of effects of rofecoxib on platelet function in an in vitro model of thrombosis with circulating human bloodHERNANDEZ, M. R; TONDA, R; PINO, M et al.European journal of clinical investigation. 2004, Vol 34, Num 4, pp 297-302, issn 0014-2972, 6 p.Article

Effect of cyclooxygenase-2 inhibitors on blood pressureJOHNSON, Deanna L; HISEL, Tina M; PHILLIPS, Beth Bryles et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 3, pp 442-446, issn 1060-0280, 5 p.Article

Chemoprevention of mammary carcinogenesis in female rats by rofecoxibKUBATKA, Peter; AHLERS, Ivan; AHLERSOVA, Eva et al.Cancer letters. 2003, Vol 202, Num 2, pp 131-136, issn 0304-3835, 6 p.Article